Navigation Links
Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis
Date:4/3/2013

1 study of ISIS-APOARx is a blinded, placebo-controlled, dose-escalation study in approximately 56 healthy volunteers.  The study is designed to assess the safety, tolerability and pharmacokinetics of both single and multiple doses of ISIS-APOARx

ABOUT Lp(a)

Lp(a) is considered an independent risk factor for cardiovascular disease due to its association with an increased risk of coronary heart disease and atherosclerotic plaque formation.  Lp(a) is a lipoprotein particle that is assembled in the liver that consists of an LDL-C-like particle and apolipoprotein(a).  Lp(a) levels in blood can vary greatly between individuals due primarily to genetic variations in the gene that encodes for apolipoprotein(a).  As a result, Lp(a) levels are genetically determined, reached by the age of two and remain constant throughout the life of the individual.  Diet and lifestyle changes have little impact on Lp(a) levels and currently therapies are not able to adequately reduce elevated levels of Lp(a) to acceptable levels in patients who have severely elevated Lp(a).   As a general guideline for ideal Lp(a) levels, the European Atherosclerosis Society recommends that Lp(a) levels be less than or equal to 50 mg/dL.  ISIS-APOARx is designed to selectively reduce levels of Lp(a) by inhibiting the production of apolipoprotein(a).

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing mar
'/>"/>

SOURCE Isis Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
2. Catabasis Initiates Phase 1 Trial of CAT-2003 for Treatment of Severe Hypertriglyceridemia
3. Alliqua Initiates Life-Cycle Management Plan to Expand Wound Care Portfolio for Use in Broader Wound Indications
4. Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat
5. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
6. NxStage Initiates 2013 Call to Action Campaign with Launch of Hemodialysis At Home: A Better Way For a Better Life
7. Coyote Pharmaceuticals Initiates GMP Manufacturing Process for CNS-102 Following Successful Pre-IND Meeting
8. Nanomix Initiates Clinical Testing of Point of Care IVD Cardiac Panel
9. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
10. uniQure Initiates Phase I in Acute Intermittent Porphyria
11. Fate Therapeutics Initiates Phase 2 Clinical Study of ProHema for the Treatment of Hematologic Malignancies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Aug. 26, 2014  When it comes to diabetes supplies, ... relevance. But Timesulin happens to answer a real medical ... pen on the market, Timesulin shows how long it,s ... preventing from missed or double insulin doses. Very easy ... back on the insulin pen after an injection. There ...
(Date:8/26/2014)... 26, 2014 Acelleron Medical Products of ... ., is expanding.  Acelleron, a home medical equipment provider, ... division, Acelleron Maternal Health & Wellness (MHW), to offer a ... full range of resources for pregnant women and families. ... director of maternal wellness. Vecchi, the former owner of Maternal ...
(Date:8/26/2014)... TUCSON, Ariz. , Aug. 26, 2014 ... Artificial Heart, is high on the Inc. 5000 named ... "SynCardia manufactures the world,s only FDA, Health Canada and ... a bridge to a matching donor heart transplant," says ... "It has become the standard of care for patients ...
Breaking Medicine Technology:Montméd obtains reimbursement of Timesulin, the smart insulin pen timer cap, by major insurance companies in Canada 2Suzanne Vecchi Named Director of Newly Acquired Acelleron Maternal Health & Wellness 2Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2
... Cumberland Pharmaceuticals Inc. (Nasdaq: ... from the U.S. Food and Drug Administration (FDA) for ... the Company,s product used to treat acetaminophen poisoning. The ... tetracetic acid or any other stabilization and chelating agents ...
... Marshals, acting under a court order sought by the ... 6, seized all dental devices from Rite-Dent Manufacturing Corporation, ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The seizure of dentistry ... found significant deficiencies in the company,s manufacturing processes that ...
Cached Medicine Technology:Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 2Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 3Cumberland Pharmaceuticals Receives FDA Approval for New Formulation of Acetadote 4U.S. Marshals Seize Dental Devices From Florida Manufacturer 2
(Date:8/27/2014)... one of the most loved online bamboo product suppliers; the ... Recently, it has announced its new selection of bamboo ... to offer one-stop shopping solutions for people who want to ... is providing big discounts for all the brand new bamboo ... discounted price (up to 30% off) before the deadline on ...
(Date:8/27/2014)... 27, 2014 IntelliSoft Group, LLC, a ... software, will unveil IntelliCred, IntelliApp and IntelliContract ... Medical Staff Services (NHAMSS) Annual Conference on September 16, ... Bedford, NH. , Notable improvements available in IntelliSoft’s ... , Contract Linking: A new Contract Connection Tab ...
(Date:8/27/2014)... August 27, 2014 President Obama is ... immigration. A White House initiative that supplies green ... undocumented immigrants would also open a pathway to Social ... , Access to work authorization would add new ... the program is the target of proposals to cut ...
(Date:8/27/2014)... August 27, 2014 Janice Holly Booth ... necessity when no-one would join her on an adventure outing ... an extreme sport involving ropes, harnesses and rappelling into mysterious, ... with solo travel but definitely not my last,” she says. ... that pushed me to the edge, and experienced first-hand the ...
(Date:8/27/2014)... 2014 *To find out more about this ... Clinical Research on the web ( http://www.achieveclinical.com ) or contact ... There is no cost to participate ... Compensation may be provided for time and travel ... that there are at least 5 million Americans living with ...
Breaking Medicine News(10 mins):Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:IntelliSoft Group to Unveil Version 14.2 of IntelliCred, IntelliApp and IntelliContract at the New Hampshire Association of Medical Staff Services Annual Conference 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:Best-selling Author Janice Holly Booth Offers Tips to Navigating Fear and Living a Fuller Life 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 2Health News:Achieve Clinical Research Is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial in Birmingham, Alabama 3
... in Canadian hospitals, way beyond estimation, raising concern among ... investigator in the study said, “The stark reality in ... and other drug-resistant bacteria are posing a serious threat ... these super bugs are more likely to have longer ...
... a drug charity has revealed that young men are ... looks as well as to boost their self-confidence.// ... body builders and athletes to improve their performance, were ... building site workers between the ages 16 and 25. ...
... been developed by a researcher from Cornell University that detects ... in food processing.// , ‘It’s very inexpensive, it ... and it could be activated for whatever you want to ... Professor of Fibre Science and Apparel Design at Cornell. ...
... next week the distribution of a drug to help fight ... Africa is being affected by an extremely virulent strain of ... in the country. The health officials have now promised that ... next week to help fight the disease. The officials but ...
... properly for their safety and efficacy, says a ... // The drugs that are being indiscriminately prescribed ... ,The researchers analyzed drugs covered by a "congressionally ... the Food and Drug Administration (FDA) may extend ...
... branded inhalation capsules in India for the treatment of ... Beta2-agonist Formoterol and the most potent inhaled corticosteroid Fluticasone, ... 100 mcg, Avessa 250 mcg, Avessa 500 mcg, depending ... product is to be used only with the Rheohaler ...
Cached Medicine News:Health News:Nanotech Wipes for biohazard detection 2Health News:South Africa To Make Available Two New Drugs To Fight The TB Outbreak 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3
... and microplatesthat is the area of research ... an ever-increasing force. Ergonomics (reduced weight and ... that the Multichannel Research model was developed. ... effective, precise, and rapid processing of long ...
... and Benefits: 1-8channel pipette This ... product number, created to easily ... showing no availability yet, please ... number (Z37,174-2) or contact customer ...
... Hamilton is precision, ergonomics, and value!, ... soft non-slip, contoured handle , Finer control ... action , Stress-free tip ejection with long, ... easy decontamination and sterilization without the need ...
... Finnpipette Focus multichannel pipettes ... of reagents into microplates, ... 0.1-10 l volumes. The ... Finnpipette Focus multichannels, combined ...
Medicine Products: